Yuval Adar
Director/Board Member bei HBL - HADASIT BIO-HOLDINGS LTD
Profil
Yuval Adar has worked as a Director at Hadasit Medical Research Services & Development Ltd.
since 2014 and at HBL- Hadasit Bio-Holdings Ltd.
since 2021.
Aktive Positionen von Yuval Adar
| Unternehmen | Position | Beginn |
|---|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Director/Board Member | 19.07.2021 |
Hadasit Medical Research Services & Development Ltd.
 Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Director/Board Member | 09.08.2014 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Finance |
| Private Unternehmen | 1 |
|---|---|
Hadasit Medical Research Services & Development Ltd.
Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Commercial Services |
